Jushi Holdings Inc JUSHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if JUSHF is a good fit for your portfolio.
News
-
Jushi Holdings Inc. Appoints Todd West as Chief Operating Officer
-
Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Virginia's adult-use cannabis bill could become law, even if the governor fails to act
-
Jushi Holdings Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
-
Jushi Announces Support of Adult-Use Cannabis in Pennsylvania Governor’s Annual Budget Proposal and Address
-
HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain
Trading Information
- Previous Close Price
- $0.67
- Day Range
- $0.65–0.69
- 52-Week Range
- $0.35–1.09
- Bid/Ask
- $0.66 / $0.68
- Market Cap
- $131.37 Mil
- Volume/Avg
- 37,627 / 342,039
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.49
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Jushi Holdings Inc is a vertically integrated multi-state cannabis and hemp operator engaged in retail, distribution, cultivation, and processing in both medical and adult-use markets. The company operates a diverse portfolio of branded cannabis and hemp-derived assets, built upon opportunistic acquisitions, distressed deals, and competitive applications. Operating under the Jushi umbrella is the BEYOND / HELLO retail brand of cannabis dispensaries, hemp-based CBD brand, Nira, including its brands, The Lab: Concentrates and The Bank: Flower + Genetics, as well as its precision-formulated line of medical cannabis products Nira Plus. Jushi strives to maximize shareholder value while delivering high-premium products across all levels of the cannabis and hemp ecosystem.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,188
- Website
- https://www.jushico.com
Comparables
Valuation
Metric
|
JUSHF
|
CL
|
GLAS.A.U
|
---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | — | 1.47 | 6.98 |
Price/Sales | 0.49 | 0.90 | 3.95 |
Price/Cash Flow | 16.12 | 16.04 | 67.91 |
Price/Earnings
JUSHF
CL
GLAS.A.U
Financial Strength
Metric
|
JUSHF
|
CL
|
GLAS.A.U
|
---|---|---|---|
Quick Ratio | 0.24 | 0.78 | 0.38 |
Current Ratio | 0.50 | 1.39 | 0.56 |
Interest Coverage | 0.10 | −1.36 | −7.98 |
Quick Ratio
JUSHF
CL
GLAS.A.U
Profitability
Metric
|
JUSHF
|
CL
|
GLAS.A.U
|
---|---|---|---|
Return on Assets (Normalized) | −9.23% | −3.12% | −7.05% |
Return on Equity (Normalized) | −198.64% | −8.02% | −18.87% |
Return on Invested Capital (Normalized) | −5.93% | −0.11% | −6.36% |
Return on Assets
JUSHF
CL
GLAS.A.U
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Rmnkjztn | Hycg | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Gflrphycw | Bnfvvl | $68.1 Bil | |
HLN
| Haleon PLC ADR | Mnzfrjh | Pghp | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Mppnvql | Dsl | $14.3 Bil | |
VTRS
| Viatris Inc | Njgqrgdym | Kjldq | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kjdynxvrj | Fccvj | $12.0 Bil | |
CTLT
| Catalent Inc | Ybnbyczmy | Zfbcz | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Qqgsysbd | Qxgjt | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Lmndpclg | Gfnf | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Txtsqxndk | Dxxvyc | $3.4 Bil |